93 related articles for article (PubMed ID: 11899627)
1. Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study.
Rummel MA; Donnelly PJ; Fortenbaugh CC
Clin J Oncol Nurs; 2001; 5(6):261-5. PubMed ID: 11899627
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
4. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.
Heaton DC; Han DY; Inder A
Intern Med J; 2002 Mar; 32(3):84-8. PubMed ID: 11885848
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters.
Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP
Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197
[TBL] [Abstract][Full Text] [Related]
6. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
Harris JL; Maguire D
J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
[TBL] [Abstract][Full Text] [Related]
7. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
8. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device.
Jacobs BR; Schilling S; Doellman D; Hutchinson N; Rickey M; Nelson S
JPEN J Parenter Enteral Nutr; 2004; 28(2):113-8. PubMed ID: 15080606
[TBL] [Abstract][Full Text] [Related]
9. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
Rawson KM; Newburn-Cook CV
Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
[TBL] [Abstract][Full Text] [Related]
10. Exchanging dual-lumen central venous catheters: how I do it.
Chaitowitz I; Heng R; Bell KW
Australas Radiol; 2007 Apr; 51(2):106-9. PubMed ID: 17419853
[TBL] [Abstract][Full Text] [Related]
11. Occlusion reduction and heparin elimination trial using an antireflux device on peripheral and central venous catheters.
Jasinsky LM; Wurster J
J Infus Nurs; 2009; 32(1):33-9. PubMed ID: 19142148
[TBL] [Abstract][Full Text] [Related]
12. Use of the femoral vein as insertion site for tunneled hemodialysis catheters.
Falk A
J Vasc Interv Radiol; 2007 Feb; 18(2):217-25. PubMed ID: 17327554
[TBL] [Abstract][Full Text] [Related]
13. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
[TBL] [Abstract][Full Text] [Related]
14. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure Luer-activated devices.
Bowers L; Speroni KG; Jones L; Atherton M
J Infus Nurs; 2008; 31(1):22-7. PubMed ID: 18202556
[TBL] [Abstract][Full Text] [Related]
15. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
16. Treatment of catheter occlusion in pediatric patients.
Kerner JA; Garcia-Careaga MG; Fisher AA; Poole RL
JPEN J Parenter Enteral Nutr; 2006; 30(1 Suppl):S73-81. PubMed ID: 16387916
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
18. Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Kirkpatrick A; Rathbun S; Whitsett T; Raskob G
Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462
[TBL] [Abstract][Full Text] [Related]
19. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
20. Surface-treated catheters--a review.
Dwyer A
Semin Dial; 2008; 21(6):542-6. PubMed ID: 19000120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
